Zoetis PE Ratio 2011-2018 | ZTS

Current and historical p/e ratio for Zoetis (ZTS) from 2011 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Zoetis PE ratio as of April 25, 2019 is 32.20.
Zoetis PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-04-25 101.83 34.75
2018-12-31 85.37 $2.93 29.14
2018-09-30 91.25 $2.38 38.34
2018-06-30 84.78 $2.28 37.18
2018-03-31 82.99 $1.99 41.70
2017-12-31 71.47 $1.75 40.84
2017-09-30 63.16 $1.90 33.24
2017-06-30 61.79 $1.77 34.91
2017-03-31 52.67 $1.72 30.62
2016-12-31 52.73 $1.65 31.96
2016-09-30 51.13 $1.38 37.05
2016-06-30 46.65 $1.28 36.45
2016-03-31 43.40 $0.76 57.10
2015-12-31 46.81 $0.68 68.84
2015-09-30 40.16 $0.89 45.12
2015-06-30 46.94 $0.84 55.88
2015-03-31 44.98 $1.18 38.12
2014-12-31 41.73 $1.16 35.98
2014-09-30 35.77 $1.12 31.94
2014-06-30 31.17 $1.05 29.69
2014-03-31 27.89 $1.04 26.81
2013-12-31 31.43 $1.01 31.12
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $48.449B $5.825B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $28.732B 10.63
Grifols (GRFS) Spain $13.029B 15.92
Ionis Pharmaceuticals (IONS) United States $10.149B 31.47
Sage Therapeutics (SAGE) United States $7.745B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.384B 10.57
Neurocrine Biosciences (NBIX) United States $7.222B 465.47
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.420B 8.65
Tilray (TLRY) United States $4.965B 0.00
United Therapeutics (UTHR) United States $4.525B 7.70
Taro Pharmaceutical Industries (TARO) Israel $4.215B 13.57
FibroGen (FGEN) United States $4.055B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.722B 0.00
Portola Pharmaceuticals (PTLA) United States $2.432B 0.00
PTC Therapeutics (PTCT) United States $2.163B 0.00
USANA Health Sciences (USNA) United States $1.904B 15.97
Ironwood Pharmaceuticals (IRWD) United States $1.846B 0.00
Heron Therapeutics (HRTX) United States $1.840B 0.00
Xencor (XNCR) United States $1.792B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.784B 0.00
Aerie Pharmaceuticals (AERI) United States $1.783B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.696B 21.12
Endo (ENDP) Ireland $1.674B 2.58
Pacira Pharmaceuticals (PCRX) United States $1.665B 144.00
Madrigal Pharmaceuticals (MDGL) United States $1.637B 0.00
Zogenix (ZGNX) United States $1.614B 0.00
Corcept Therapeutics (CORT) United States $1.407B 20.43
Tricida (TCDA) United States $1.393B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.303B 0.00
Esperion Therapeutics (ESPR) United States $1.128B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.057B 0.00
TherapeuticsMD (TXMD) United States $0.989B 0.00
Radius Health (RDUS) United States $0.973B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.881B 0.00
CannTrust Holdings (CTST) Canada $0.799B 0.00
Akebia Therapeutics (AKBA) United States $0.752B 0.00
ChemoCentryx (CCXI) United States $0.733B 0.00
ArQule (ARQL) United States $0.693B 0.00
Odonate Therapeutics (ODT) United States $0.618B 0.00
Dermira (DERM) United States $0.593B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.582B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.571B 0.00
Forty Seven (FTSV) United States $0.561B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.554B 0.00
GlycoMimetics (GLYC) United States $0.550B 0.00
Collegium Pharmaceutical (COLL) United States $0.483B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.469B 24.21
Corbus Pharmaceuticals Holdings (CRBP) United States $0.461B 0.00
Siga Technologies (SIGA) United States $0.429B 0.00
Translate Bio (TBIO) United States $0.426B 0.00
Flexion Therapeutics (FLXN) United States $0.416B 0.00
KalVista Pharmaceuticals (KALV) United States $0.414B 0.00
OptiNose (OPTN) United States $0.410B 0.00
Aptorum Group (APM) China $0.399B 0.00
TCR2 THERAPTCS (TCRR) United States $0.388B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 0.00
Mast Therapeutics (SVRA) United States $0.370B 0.00
ImmunoGen (IMGN) United States $0.363B 0.00
CASI Pharmaceuticals (CASI) United States $0.316B 0.00
Karyopharm Therapeutics (KPTI) United States $0.296B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.291B 0.00
Minerva Neurosciences (NERV) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.282B 2.62
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.277B 10.26
Harpoon Therapy (HARP) United States $0.273B 0.00
Aclaris Therapeutics (ACRS) United States $0.264B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.257B 0.00
Xeris Pharmaceuticals (XERS) United States $0.249B 0.00
Calithera Biosciences (CALA) United States $0.247B 0.00
Dova Pharmaceuticals (DOVA) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.234B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.234B 0.00
Concert Pharmaceuticals (CNCE) United States $0.225B 0.00
Aldeyra Therapeutics (ALDX) United States $0.223B 0.00
MEI Pharma (MEIP) United States $0.221B 0.00
Rafael Holdings (RFL) United States $0.220B 0.00
Galectin Therapeutics (GALT) United States $0.218B 0.00
Affimed (AFMD) Germany $0.210B 0.00
Ardelyx (ARDX) United States $0.207B 0.00
Opexa Therapeutics (ACER) United States $0.201B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.197B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Majesco Entertainment (PTE) United States $0.186B 0.00
Recro Pharma (REPH) United States $0.183B 0.00
Nature's Sunshine Products (NATR) United States $0.179B 185.60
AgeX Therapeutics (AGE) United States $0.177B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.177B 0.00
ElectroCore (ECOR) United States $0.173B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.173B 0.00
Redhill Biopharma (RDHL) Israel $0.172B 0.00
Ocular Therapeutix (OCUL) United States $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.167B 0.00
Neon Therapeutics (NTGN) United States $0.166B 0.00
IMV INC (IMV) Canada $0.161B 0.00
Tyme Technologies (TYME) United States $0.154B 0.00
Aquestive Therapeutics (AQST) United States $0.147B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.143B 0.00
MediWound (MDWD) Israel $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.134B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Iterum Therapeutics (ITRM) Ireland $0.113B 0.00
China SXT Pharmaceuticals (SXTC) China $0.113B 0.00
Neos Therapeutics (NEOS) United States $0.111B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.098B 0.00
Natural Alternatives (NAII) United States $0.097B 9.46
Adamis Pharmaceuticals (ADMP) United States $0.093B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.092B 0.00
DURECT (DRRX) United States $0.092B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.090B 0.00
Nivalis Therapeutics (ALPN) United States $0.090B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Zafgen (ZFGN) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.088B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Avenue Therapeutics (ATXI) United States $0.078B 0.00
Genocea Biosciences (GNCA) United States $0.076B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.066B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.059B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.059B 0.00
CTI BioPharma (CTIC) United States $0.058B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.047B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.044B 0.00
KemPharm (KMPH) United States $0.043B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.042B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.034B 0.00
Shineco (TYHT) China $0.030B 5.08
HANCOCK JAFFE (HJLI) United States $0.029B 0.00
IsoRay (ISR) United States $0.028B 0.00
Achieve Life Sciences (ACHV) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 3.38
PharmAthene (ALT) United States $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NanoViricides (NNVC) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Xenetic Biosciences (XBIO) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.87
PRECISION THERAPEUTICS INC (AIPT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Achaogen (AKAO) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00